Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Patent
1998-06-01
1999-10-26
Bawa, Raj
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
424451, 424463, 424474, 424490, 514962, 514324, 514960, A61K 920, A61K 31445
Patent
active
059723831
ABSTRACT:
This invention provides orally administerable pharmaceutical formulations comprising raloxifene, its ethers or esters, or a pharmaceutically-acceptable salt thereof, in combination with a hydrophilic carrier composition.
REFERENCES:
patent: 4133814 (1979-01-01), Jones et al.
patent: 4418068 (1983-11-01), Jones
patent: 5461064 (1995-10-01), Cullinan
patent: 5462950 (1995-10-01), Fontana
patent: 5510370 (1996-04-01), Hock
van Hoogdalem et al., Pharmac. Ther., 44, 407 (1989).
Dissolution, Bioavailability, and Bioequivalende, (1989), Chapter 5, Factors Affecting the Rate of Dissolution of Solid Dosage Forms, Mack Publishing Co., PA.
Gibson Lowell L.
Hartauer Kerry J.
Stowers Julian L.
Sweetana Stephanie A.
Thakkar Arvind L.
Bawa Raj
Eli Lilly and Company
Sales James J.
LandOfFree
Solid orally administerable raloxifene hydrochloride pharmaceuti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Solid orally administerable raloxifene hydrochloride pharmaceuti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Solid orally administerable raloxifene hydrochloride pharmaceuti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-761022